Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression
Background/aim: T-cell immunotherapies are rapidly gaining grounds in clinical success. Presently, there is first-to-market knowledge on the translation of research scale methods to clinical and commercial scales. Improved understanding can lead to more consistent and efficient production, scaling,...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2019-04-01
|
| Serie: | Autoimmunity |
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.1080/08916934.2019.1630064 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|